Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vactosertib for Anemia in Ph-negative MPNs
NCT04103645Phase 2Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Nov 2019
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vactosertib in myeloproliferative neoplasms (MPN), sponsored by Weill Cornell Medicine. Started Nov 2019; status: terminated.
02
Drugs
vactosertib
03
Conditions
myeloproliferative neoplasms (MPN)
Beyond the preview
Go deeper on NCT04103645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04103645.